Jefferies Group’s Niagen Bioscience NAGE Stock Holding History

Jefferies Group’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-14,000	Closed	-$59K	–	2750
2018 Q1	$59K	Buy	+14,000	New	+$73.3K	﹤0.01%	2110

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jefferies Group's NAGE Position: Q2 2018 in Review

Jefferies Group sold out of Niagen Bioscience (NAGE) in Q2 2018, closing a stake of 14,000 shares — an estimated $59K sold.

Jefferies Group first reported a position in NAGE in Q1 2018 and held it in 1 quarter. The position peaked at $59K in Q1 2018. 64 funds tracked by Wall St. Rank hold NAGE as of Q2 2018.

Jefferies Group reported no remaining Niagen Bioscience position as of Q2 2018 after selling out during the quarter.
Jefferies Group sold 14,000 Niagen Bioscience shares in Q2 2018, an estimated $59K.
Jefferies Group first reported a position in Niagen Bioscience in Q1 2018 and held it in 1 quarter.
Jefferies Group's Niagen Bioscience position peaked at $59K in Q1 2018.
64 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2018.

Based on Jefferies Group's 13F filing for Q2 2018, filed 14 Aug 2018.